SCHEMBL9516276

SCHEMBL9516276

O=CCC(c1ccc(C(F)(F)F)cc1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
HDAC3 O15379 3/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
P4HTM Q9NXG6 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515967 0.90 HIF1A (0.38) HIF1AEPAS1HDAC3HDAC1HDAC2
SCHEMBL9515632 0.89 MEN1 (0.38) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL9519433 0.89 NAMPT (0.39) HDAC3HDAC1HDAC2HDAC6HDAC8
SCHEMBL9519668 0.87 EGFR (0.42) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL9515768 0.86 HIF1A (0.40) HIF1AEPAS1HDAC3HDAC1HDAC2
SCHEMBL9516948 0.82 P4HTM (0.37) HDAC1HDAC6HDAC4P4HTMMEN1
SCHEMBL9516708 0.81 SLC6A9 (0.37) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL9515429 0.79 HDAC1 (0.38) HDAC3HDAC1HDAC2HDAC6HDAC8
SCHEMBL9518012 0.79 MEN1 (0.37) HDAC3HDAC1HDAC2HDAC6HDAC4
SCHEMBL9515773 0.78 HSD11B1 (0.43) HIF1AEPAS1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed